VERA-MH: Validating Ethical AI in Mental Health

• VERA-MH is a comprehensive framework that defines ethical standards for AI in mental health by integrating principles of safety, fairness, and clinical validity.
• The framework employs multidimensional rubrics and expert-validated datasets to assess risk detection, protocol adherence, and ethical integrity in sensitive scenarios.
• Evaluation pipelines combine automated metrics with human review to ensure that AI systems consistently meet stringent requirements for privacy, bias reduction, and accountability.

Validation of Ethical and Responsible AI in Mental Health (VERA-MH) refers to a set of principles, benchmarks, tools, and methodologies that provide formal, evidence-based pathways for evaluating the safety, clinical validity, fairness, and ethical integrity of AI systems deployed in mental health contexts. VERA-MH frameworks have emerged in response to rising deployment of LLMs in sensitive domains like suicide prevention, digital counseling, and psychiatric triage, where conventional technical benchmarks are insufficient to capture domain-specific risks at the intersection of autonomy, beneficence, confidentiality, bias, and stakeholder safety (Belli et al., 17 Oct 2025, Kasu, 15 Sep 2025, Bentley et al., 4 Feb 2026).

1. Foundations: Principles, Rubrics, and Pillars

VERA-MH is grounded in foundational principles drawn from medical ethics, clinical safety practices, and AI alignment literature. Multiple frameworks converge around core requirements:

• Non-maleficence and beneficence: The system must actively prevent and discourage harm, both to the user and to third parties.
• Respect for autonomy: The system should not override user agency except in emergent risk scenarios.
• Justice and fairness: The system must avoid both explicit and implicit biases along lines of race, gender, culture, and socioeconomic status.
• Confidentiality and privacy: Stringent safeguards around user data must be evident by design.
• Explainability, transparency, and accountability: Evaluation traces, scoring, and reasoning must be visible and auditable by domain experts (Grabb et al., 2024, Mörch et al., 2019, Arnaout et al., 20 Jan 2026).

The dominant scoring frameworks for VERA-MH use multi-dimensional rubrics, typically including at least five axes in suicide risk contexts: (1) risk detection, (2) risk probing, (3) appropriate action, (4) validation and collaboration, and (5) safe boundaries. Each axis is rated on a categorical or ordinal scale, such as “Best practice,” “Missed opportunity,” “Actively damaging,” or “Not relevant” (Belli et al., 17 Oct 2025, Bentley et al., 4 Feb 2026).

2. Benchmarks and Datasets

The construction and application of standardized, expert-validated benchmarks is central to VERA-MH. Notable datasets and schemas include:

• EthicsMH: 125 scenarios across five categories reflecting recurring dilemmas (confidentiality/trust, bias by race and gender, autonomy vs. beneficence for adults/minors). Each scenario contains a vignette, four decision options, expert-aligned reasoning, LLM failure mode notes, real-world impact statements, and multisided stakeholder viewpoints. Evaluation metrics encompass decision accuracy, explanation quality (e.g., token overlap, BERTScore), and normative alignment with ethical principles (Kasu, 15 Sep 2025).
• 100-question Safety Benchmark: Used to stress-test chatbot behavior on a spectrum of crisis and non-crisis queries, evaluated against ideal, evidence-based responses and multiple guideline dimensions such as protocol adherence, health risk identification, resource provision, and user empowerment (Park et al., 2024).

Benchmark realism is enforced via iterative expert review loops, ensuring coverage of real-world clinical scenarios, plausibility, and ethical trade-offs (Kasu, 15 Sep 2025, Belli et al., 17 Oct 2025). Where scale is limited, future expansion is recommended via community annotation portals, cross-cultural adaptation, and formal inter-annotator agreement measurement (e.g., Cohen’s κ) to support generalizability.

3. Evaluation Pipelines and Quantitative Metrics

VERA-MH protocols rely on modular, statistically grounded pipelines combining human and automated evaluation:

• Scoring Rubric Application: Chatbot-user conversations (often simulated via user-agent LLMs) are scored per-dimension by both licensed clinicians and AI-based “judge” agents, using structured forms with categorical and Likert-scale items. Key inter-rater reliability measures (e.g., Krippendorff’s α, raw agreement, Cohen’s κ) ensure consistency and validity (Bentley et al., 4 Feb 2026).
• Automated Metric Families: Core evaluation metrics include:
  • Decision accuracy:

  $$\mathrm{Acc} = \frac{1}{N} \sum_{i=1}^N \mathbf{1}(\hat{o}_i = o_i^*)$$ - Explanation quality:

  $$\mathrm{ExplQual} = \frac{1}{N}\sum_{i=1}^N \frac{\mathrm{Overlap}(\hat{r}_i,\,r_i^*)}{|r_i^*|}$$ - Normative alignment:

  $$\mathrm{Align} = \frac{1}{N}\sum_{i=1}^N \frac{1}{K} \sum_{k=1}^K \mathbf{1}(\hat{a}_{i,k}=a^*_{i,k})$$ - Safety Risk Index (SRI):

  $$\mathrm{SRI} = \frac{\#\text{unsafe turns}}{\#\text{total turns}}$$ - Empathy indices, calibration error, and bias scores (groupwise differences) are reported per-section for fairness and empathic quality (Kasu, 15 Sep 2025, Badawi et al., 21 Feb 2025, Arnaout et al., 20 Jan 2026, AlMakinah et al., 2024, Park et al., 2024).

• LLM-as-Judge and Agentic Approaches: Automated scoring can use LLMs as “judges” aligned to expert rubrics (typically GPT-4o, Claude Opus, or Gemini). Retrieval-augmented agentic methods, which access real-time evidence, result in highest alignment with human professionals (e.g., Pearson r = 0.84, MAE = 0.31 in (Park et al., 2024)).
• Human-in-the-loop and Continuous Monitoring: Evaluation includes human audit/review for low-alignment or high-risk outputs, simulation of diverse user-agent personas, red/blue-team stress-testing, and periodic re-validation as models or use-cases evolve (Kasu, 15 Sep 2025, Belli et al., 17 Oct 2025).

4. Engineering Solutions and Implementation Practices

Implementation of VERA-MH philosophy is technologically anchored in:

• SAFE-i Guidelines: Prescribes (Supportive, Adaptive, Fair, Ethical) practices including encrypted data governance, continuous domain-adaptive tuning, fairness regularization (e.g., demographic parity weighting, groupwise loss constraints), differential privacy (DP-SGD with formal $(\epsilon, \delta)$ bounds), auditable logs, and explainability with citation of clinical references (Badawi et al., 21 Feb 2025).
• Federated Learning and Privacy-Preserving Modeling: Multi-institutional federated training reduces data bias and enables privacy guarantees. Differentially private gradient sharing, homomorphic encryption, and per-site clinician review enforce both ethical and technical constraints. Bias reduction is operationalized through dynamic reweighting (e.g., $r_k \propto 1/\text{error}_k$), Lagrangian fairness constraints (equalized odds), and continuous empathy scoring (AlMakinah et al., 2024).
• Autonomy Taxonomy: AI autonomy is staged, only expanding to new tasks (triage, diagnosis, treatment, monitoring, documentation) upon demonstrated perfect safety (i.e., $S_{\text{unsafe}}=0$) across pre-specified test scenarios. This phased release model enforces maximal oversight on the most critical functionalities (Grabb et al., 2024).
• Human-AI Evaluation Loops: VERA-MH pipelines embed weekly expert panel reviews to diagnose flagged failures, update data pipelines, and re-tune models, closing the loop between model performance and real-world safety/efficacy (Badawi et al., 21 Feb 2025, Arnaout et al., 20 Jan 2026).

5. Validation Studies and Empirical Results

Empirical validation has shown that VERA-MH–aligned evaluation protocols can robustly operationalize clinical expert consensus:

• Observed inter-rater reliability (Krippendorff’s α ≈ 0.77–0.81, raw agreement ≥ 81%) demonstrates high consistency among clinicians and between clinicians and leading LLM judges (Bentley et al., 4 Feb 2026).
• GPT-5 scored >90% Best-practice across rubric dimensions for suicide risk scenarios, outperforming Claude Opus and Sonnet on probing and action-taking (Belli et al., 17 Oct 2025).
• Automated (LLM- or embedding-based) evaluation approaches can achieve high correlation with human expert scoring, though retrieval-augmented “agentic” evaluators yield the most reliable results.
• Federated learning pilots report improved classification accuracy (to 81.7%), F1-score rise (to 0.78), Empathy Index growth (+0.22), and reduced bias across demographics (BiasScore reduction from 0.18 to 0.06), with DP privacy budgets managed to $\varepsilon_\mathrm{tot}\approx 8.7$ (AlMakinah et al., 2024).
• Limitations include scenario and demographic coverage, prompt drift, disclosure realism, and the necessity of continuous annotation and rubric revision to cover emerging LLM failure modes.

6. Governance, Checklists, and Stakeholder Integration

Comprehensive governance frameworks such as the Canada Protocol-MHSP supply validated checklists (38 items, five domains: description, privacy, security, health risks, bias) activated through Delphi consensus for systematic documentation, oversight, and pre-deployment review (Mörch et al., 2019). VERA-MH emphasizes cross-role participation:

• Clinicians derive and validate benchmarks.
• End-users and patients supply acceptability and engagement data.
• Implementation scientists and regulators provide feasibility/scalability oversight. Tailoring of checklists and language ensures compatibility for developers, clinicians, and regulators.

Best practice recommendations include mandatory scenario-based vetting, active safety logging, open reporting templates, and explicit opt-in/opt-out and re-consent provisions to guarantee regulatory compliance and stakeholder trust (Arnaout et al., 20 Jan 2026, Mörch et al., 2019, Kasu, 15 Sep 2025).

7. Outlook and Future Directions

Scaling VERA-MH will involve expanding scenario datasets (including minors, systemic inequities, health insurance interactions), cross-jurisdictional adaptation, higher inter-annotator agreement standards, dynamic scenario refreshes for new AI failure types, and deployment of more advanced fairness and privacy tools. Empirical grounding across multiple clinical cultures, integration of multimodal signals (voice, video), and linkage of evaluation outcomes to real-world treatment gains (e.g., PHQ-9 reduction) remain critical for advancing the responsible adoption of AI in mental health (Badawi et al., 21 Feb 2025, Belli et al., 17 Oct 2025, AlMakinah et al., 2024).

By embedding rigorous, multidimensional validation pipelines at research, development, and deployment stages, VERA-MH offers a scalable, auditable, and adaptable standard for evaluating ethical and responsible AI in mental health—ensuring not only technical competency but also domain-appropriate, stakeholder-aligned safety and fairness.